alpha-Synuclein interacts with phospholipase D isozymes and inhibits pervanadate-induced phospholipase D activation in human embryonic kidney-293 cells
about
sameAs
The role of oxidative stress in Parkinson's diseaseEvidence that alpha-synuclein does not inhibit phospholipase DTransmodulation between phospholipase D and c-Src enhances cell proliferationAlpha-synuclein structure, functions, and interactionsThe phosphorylation of α-synuclein: development and implication for the mechanism and therapy of the Parkinson's diseasePhosphorylation at S87 is enhanced in synucleinopathies, inhibits alpha-synuclein oligomerization, and influences synuclein-membrane interactionsα-Synuclein-induced tubule formation in lipid bilayersSerine 129 phosphorylation reduces the ability of alpha-synuclein to regulate tyrosine hydroxylase and protein phosphatase 2A in vitro and in vivo.Regulation of Weibel-Palade body exocytosis by alpha-synuclein in endothelial cells.α-Synuclein expression in rat substantia nigra suppresses phospholipase D2 toxicity and nigral neurodegeneration.Phospholipase D signaling pathways and phosphatidic acid as therapeutic targets in cancerParkin and alpha-synuclein: opponent actions in the pathogenesis of Parkinson's disease.Beta-synuclein regulates Akt activity in neuronal cells. A possible mechanism for neuroprotection in Parkinson's disease.Conformational heterogeneity of α-synuclein in membrane.A calcineurin- and NFAT-dependent pathway is involved in α-synuclein-induced degeneration of midbrain dopaminergic neurons.Alpha-synuclein function and dysfunction on cellular membranes.Expression of mutant alpha-synuclein modulates microglial phenotype in vitroPhospholipase D: enzymology, functionality, and chemical modulationDid α-Synuclein and Glucocerebrosidase Coevolve? Implications for Parkinson's Disease.Phospholipase D in brain function and Alzheimer's disease.Helix periodicity, topology, and dynamics of membrane-associated alpha-synuclein.Brain prostaglandin formation is increased by alpha-synuclein gene-ablation during global ischemia.Molecular mechanisms of alpha-synuclein neurodegeneration.Cell death pathways in Parkinson's disease: proximal triggers, distal effectors, and final steps.In vitro phosphorylation does not influence the aggregation kinetics of WT α-synuclein in contrast to its phosphorylation mutants.Insights into the PX (phox-homology) domain and SNX (sorting nexin) protein families: structures, functions and roles in disease.Mechanisms of alpha-synuclein action on neurotransmission: cell-autonomous and non-cell autonomous roleCell Biology and Pathophysiology of α-Synuclein.Genetic Determinants of Parkinson's Disease: Can They Help to Stratify the Patients Based on the Underlying Molecular Defect?Parkinson's disease: genetics and beyond.Adsorption of alpha-synuclein on lipid bilayers: modulating the structure and stability of protein assemblies.Elucidating the role of C-terminal post-translational modifications using protein semisynthesis strategies: α-synuclein phosphorylation at tyrosine 125.The therapeutic potential of LRRK2 and alpha-synuclein in Parkinson's disease.Mitochondrial Dysfunction: The Road to Alpha-Synuclein Oligomerization in PD.Posttranslational modifications of blood-derived alpha-synuclein as biochemical markers for Parkinson's disease.Potential of caveolae in the therapy of cardiovascular and neurological diseases.A combinatorial code for the interaction of alpha-synuclein with membranes.Phosphorylated α-Synuclein-Copper Complex Formation in the Pathogenesis of Parkinson's Disease.Melatonin reduces the expression of alpha-synuclein in the dopamine containing neuronal regions of amphetamine-treated postnatal rats.Exploring the role of post-translational modifications in regulating α-synuclein interactions by studying the effects of phosphorylation on nanobody binding.
P2860
Q24307946-BCD00884-BF25-4B45-8B52-0C2769049FA6Q24316900-061AA269-EB53-4D96-9E67-1EBB87DA5329Q24682831-7A529CF8-1DCE-48FB-ABA2-68FE9C4A931BQ28075526-56A70786-6B76-466B-AFFF-0E036ECD80F7Q28087330-5E38C37D-11CF-48A4-831D-CEC3DFBF9B3FQ30496792-E632309D-196D-46DE-8B9E-C28A4E7B51CAQ30500318-8AE1702B-D37C-4532-BE71-52F4E1BD2804Q33885205-3CE85CAC-AB52-4D14-92B5-4DA3ED693B8FQ33967323-C15564C2-CCB9-435B-ABC0-F2979B676E19Q34183367-BDC66565-B476-45CD-BFCF-0512E3B857CDQ34268347-FE725511-B0A3-485B-AD4F-66B871CD59A9Q34301507-00E1844E-BBF0-419E-8727-CBEAA281D00BQ34306521-EEC681A9-5C17-44F7-BD82-511B558339EEQ34325107-6B99D8CC-2A5C-4C79-8C90-887822576BFCQ34555497-35F02AA3-0A1B-42C5-BF90-9B927491DFE3Q34774324-A28EBE27-F1B6-44DB-9A7D-A131EB2C624DQ35014520-FA511B2B-0759-4882-ADA1-4D37F862CFB9Q35599714-CE49E8A8-F5E5-45B9-B8F6-D43EFDA32B36Q35716090-D330F42B-F21A-4511-871B-0F25DEC7DC1CQ35893701-FB564AB4-8260-4EB8-9C6E-D63438D5448FQ36476930-A3C3DE68-0B7D-4DE0-ADEE-49E018432860Q36507462-6DF7E754-E3CE-4154-B022-4FA857A63267Q37309838-D029F5B9-67EE-4C00-8330-62DDBE3C84A3Q37376117-8589FB60-214C-4EC9-B14D-E81F517FC9E7Q37535579-7501048E-B171-44A2-AE5A-1BD2E1C63B4FQ37968311-DD39555E-7837-4A21-A1F6-57B27E4603AEQ38488082-9954C4EE-DBA3-4B6E-BCD9-8CA61A1B69DCQ39097048-52B5B286-7A9E-4F0E-BFB3-7F124A3BB57AQ39151939-B629AD2D-6320-4ED2-BADA-0EB316A0411EQ39416222-B968754D-4A15-45C5-8A7B-202C40599A83Q40062265-A37BE145-1A00-404D-9281-1679247BDDDFQ41420722-5296BFF9-810F-4C33-9FE0-E30026A1A56EQ42116736-7D2EE439-1EF9-485A-A532-D888F206C76FQ42580316-D875CBF7-1655-4007-9EB9-98770FCC6C40Q42653035-EA597D8E-201A-421B-81F2-97657BB471B0Q42921318-23FE193A-8C70-46D5-842A-B4F8A3BB3848Q46601588-48D13B6D-21F8-420F-A1FE-B006B83B1319Q48246699-FDFD22C9-ADF4-4932-B5F2-CC79CB1D3212Q48944269-47573BCE-D7E9-4A25-A29A-12C83C63CEB3Q53823040-79FC5075-45F3-4B33-8592-D50FA2907192
P2860
alpha-Synuclein interacts with phospholipase D isozymes and inhibits pervanadate-induced phospholipase D activation in human embryonic kidney-293 cells
description
2002 nî lūn-bûn
@nan
2002 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
2002 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
2002年の論文
@ja
2002年論文
@yue
2002年論文
@zh-hant
2002年論文
@zh-hk
2002年論文
@zh-mo
2002年論文
@zh-tw
2002年论文
@wuu
name
alpha-Synuclein interacts with ...... man embryonic kidney-293 cells
@ast
alpha-Synuclein interacts with ...... man embryonic kidney-293 cells
@en
alpha-Synuclein interacts with ...... man embryonic kidney-293 cells
@nl
type
label
alpha-Synuclein interacts with ...... man embryonic kidney-293 cells
@ast
alpha-Synuclein interacts with ...... man embryonic kidney-293 cells
@en
alpha-Synuclein interacts with ...... man embryonic kidney-293 cells
@nl
prefLabel
alpha-Synuclein interacts with ...... man embryonic kidney-293 cells
@ast
alpha-Synuclein interacts with ...... man embryonic kidney-293 cells
@en
alpha-Synuclein interacts with ...... man embryonic kidney-293 cells
@nl
P2093
P3181
P356
P1476
alpha-Synuclein interacts with ...... man embryonic kidney-293 cells
@en
P2093
Benjamin Wolozin
Bong-Hyun Ahn
Do Sik Min
Hyangshuk Rhim
Jong-Soo Chang
Ju-Youn Choi
Kwang Chul Chung
Mun-Yong Lee
Myung-Suk Kim
Sang June Hahn
P304
P3181
P356
10.1074/JBC.M110414200
P407
P577
2002-04-05T00:00:00Z